Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis

BACKGROUND & AIMS: Dysmetabolic conditions could drive liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD), increasing susceptibility to hepatocellular carcinoma (HCC). We therefore aimed to identify novel predictive biomarkers of HCC in patients with and without liver fibr...

Descripción completa

Detalles Bibliográficos
Autores principales: Crudele, Lucilla, De Matteis, Carlo, Piccinin, Elena, Gadaleta, Raffaella Maria, Cariello, Marica, Di Buduo, Ersilia, Piazzolla, Giuseppina, Suppressa, Patrizia, Berardi, Elsa, Sabbà, Carlo, Moschetta, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763866/
https://www.ncbi.nlm.nih.gov/pubmed/36561127
http://dx.doi.org/10.1016/j.jhepr.2022.100627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763866/
https://www.ncbi.nlm.nih.gov/pubmed/36561127
http://dx.doi.org/10.1016/j.jhepr.2022.100627

Ejemplares similares